Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Table 1 Comparison of clinical and pathological data according to tumor localization
All patients | RCC | LCC | ||||||
(n = 942) | (n = 456) | (n = 486) | ||||||
n | % | n | % | n | % | P | ||
Age (yr) | < 65 | 636 | 67.5 | 304 | 66.7 | 332 | 68.3 | 0.590 |
≥ 65 | 306 | 32.5 | 152 | 33.3 | 154 | 31.7 | ||
Gender | Male | 511 | 54.2 | 250 | 54.8 | 261 | 53.7 | 0.730 |
Female | 431 | 45.8 | 206 | 45.2 | 225 | 46.3 | ||
Family history | No | 916 | 97.2 | 439 | 96.3 | 477 | 98.1 | 0.790 |
Yes | 26 | 2.8 | 17 | 3.7 | 9 | 1.9 | ||
Smoking status | No | 592 | 62.8 | 277 | 60.7 | 315 | 64.8 | 0.192 |
Yes | 350 | 37.2 | 179 | 39.3 | 171 | 35.2 | ||
Alcohol use status | No | 893 | 94.8 | 434 | 95.2 | 459 | 94.4 | 0.614 |
Yes | 49 | 5.2 | 22 | 4.8 | 27 | 5.6 | ||
Mode of surgery | Elective | 791 | 84 | 400 | 87.7 | 391 | 80.5 | 0.002 |
Emergent | 151 | 16 | 56 | 12.3 | 95 | 19.5 | ||
DM | No | 845 | 89.7 | 407 | 89.3 | 438 | 90.1 | 0.527 |
Yes | 93 | 9.9 | 48 | 10.5 | 45 | 9.3 | ||
HT | No | 717 | 76.1 | 344 | 75.4 | 373 | 76.7 | 0.329 |
Yes | 223 | 23.7 | 112 | 24.6 | 111 | 22.8 | ||
Histology | Adenocarcinoma | 779 | 82.7 | 356 | 78.1 | 423 | 87 | < 0.001 |
Mucinous adenocarcinoma | 163 | 17.3 | 100 | 21.9 | 63 | 13 | ||
Tumor grade | Well and moderately | 879 | 93.3 | 420 | 92.1 | 459 | 94.4 | 0.151 |
Poorly | 63 | 6.7 | 36 | 7.9 | 27 | 5.6 | ||
Tumor stage | II | 567 | 60.2 | 271 | 59.4 | 296 | 60.9 | 0.644 |
III | 375 | 39.8 | 185 | 40.6 | 190 | 39.1 | ||
pT stage | T1-2 | 133 | 14.1 | 57 | 12.5 | 76 | 15.6 | 0.267 |
T3 | 752 | 79.8 | 374 | 82 | 378 | 77.8 | ||
T4 | 57 | 6.1 | 25 | 5.5 | 32 | 6.6 | ||
The number of removed lymph nodes | < 12 | 296 | 31.4 | 102 | 22.4 | 194 | 39.9 | < 0.001 |
≥ 12 | 646 | 68.6 | 354 | 77.6 | 292 | 60.1 | ||
pN | N0 | 567 | 60.2 | 269 | 59 | 298 | 61.3 | 0.589 |
N1 | 273 | 29 | 133 | 29.2 | 140 | 28.8 | ||
N2 | 102 | 10.8 | 54 | 11.8 | 48 | 9.9 | ||
PNI | Negative | 728 | 78.3 | 354 | 78.5 | 374 | 78.1 | 0.879 |
Positive | 202 | 21.7 | 97 | 21.5 | 105 | 21.9 | ||
LVI | Negative | 629 | 67.8 | 303 | 67.3 | 326 | 68.2 | 0.777 |
Positive | 299 | 32.2 | 147 | 32.7 | 152 | 31.8 | ||
Surgical margin | Negative | 928 | 98.5 | 449 | 98.5 | 479 | 98.6 | 0.096 |
Positive | 8 | 0.8 | 6 | 1.3 | 2 | 0.4 | ||
Adjuvant treatment | No | 208 | 22.1 | 94 | 20.6 | 114 | 23.5 | 0.293 |
Yes | 734 | 77.9 | 362 | 79.4 | 372 | 76.5 | ||
Adjuvant treatment regimen | 5-FU-based | 493 | 67.2 | 243 | 67.1 | 250 | 67.2 | 0.978 |
Oxaliplatin-based | 241 | 32.8 | 119 | 32.9 | 122 | 32.8 | ||
Completion rate of adjuvant treatment | 695 | 94.7 | 344 | 95 | 351 | 94.4 | 0.685 | |
Tumor recurrence | No | 804 | 85.4 | 389 | 85.3 | 415 | 85.4 | 0.971 |
Yes | 138 | 14.6 | 67 | 14.7 | 71 | 14.6 | ||
Locoregional recurrence | 40 | 29 | 21 | 31.3 | 19 | 26.8 | 0.553 | |
Systemic recurrence | 98 | 71 | 46 | 68.7 | 52 | 73.2 | ||
Metastasectomy | 48 | 34.8 | 24 | 35.8 | 24 | 33.8 | 0.804 | |
Status | Exitus | 95 | 9.1 | 51 | 11.2 | 44 | 9.1 | 0.278 |
Alive | 847 | 90.9 | 405 | 88.8 | 486 | 90.9 | ||
Median | Min-Max | Median | Min-Max | Median | Min-Max | |||
Age (yr) | 58 | 19-94 | 57 | 19-89 | 58 | 21-94 | 0.141 | |
Follow-up (mo) | 90 | 1-252 | 90 | 1-252 | 90 | 5-235 | ||
mean | SD | mean | SD | mean | SD | |||
Number of removed lymph nodes | 17.57 | 10.843 | 19.78 | 11.059 | 15.5 | 10.223 | < 0.001 | |
Number of metastatic lymph nodes | 1.46 | 4.068 | 1.41 | 2.86 | 1.5 | 4.944 | 0.743 |
Table 2 Disease free survival and overall survival rates (%) at 12, 36, 60, 90, 120 and 180 mo according to tumor localization
All patients (%) | RCC (%) | LCC (%) | |||
DFS (mo) | Stage II | Stage III | Stage II | Stage III | |
12 | 97.9 | 98.9 | 96.2 | 98.0 | 96.8 |
36 | 89.8 | 93.9 | 83.6 | 94.5 | 81.9 |
60 | 87.0 | 93.1 | 79.4 | 91.8 | 78.2 |
90 | 84.9 | 92.6 | 75.9 | 91.3 | 76.7 |
120 | 84.4 | 92.0 | 75.0 | 90.5 | 74.4 |
180 | 82.7 | 90.3 | 73.2 | 90.5 | 72.2 |
OS (mo) | |||||
12 | 99.8 | 99.3 | 100.0 | 99.7 | 100.0 |
36 | 96.7 | 96.2 | 95.5 | 99.3 | 94.4 |
60 | 92.4 | 94.5 | 86.2 | 97.0 | 87.9 |
90 | 89.5 | 94.0 | 82.5 | 94.4 | 86.4 |
120 | 87.6 | 92.7 | 78.9 | 93.8 | 82.9 |
180 | 86.6 | 92.7 | 78.9 | 92.1 | 82.9 |
Table 3 Factors affecting disease free survival
Univariate analysis | Multivariate analysis | ||||||||||||
HR | 95%CI | P | HR | 95%CI | P | ||||||||
Age (yr) | < 65 | 1 | 1 | ||||||||||
≥ 65 | 1.779 | 1.268 | 2.496 | 0.001 | 1.88 | 1.305 | 2.708 | 0.001 | |||||
Gender | Male | 1 | |||||||||||
Female | 0.96 | 0.686 | 1.343 | 0.812 | |||||||||
Family history | No | 1 | |||||||||||
Yes | 1.195 | 0.489 | 2.919 | 0.696 | |||||||||
Smoking status | No | 1 | |||||||||||
Yes | 0.908 | 0.641 | 1.287 | 0.587 | |||||||||
Alcohol using status | No | 1 | |||||||||||
Yes | 0.372 | 0.118 | 1.167 | 0.09 | |||||||||
Mode of surgery | Elective | 1 | 1 | ||||||||||
Emergent | 1.796 | 1.22 | 2.646 | 0.003 | 1.718 | 1.131 | 2.611 | 0.011 | |||||
DM | No | 1 | |||||||||||
Yes | 0.973 | 0.549 | 1.724 | 0.925 | |||||||||
HT | No | 1 | |||||||||||
Yes | 1.541 | 0.967 | 2.224 | 0.067 | |||||||||
Histology | Adenocarcinoma | 1 | |||||||||||
Mucinous adenocarcinoma | 1.207 | 0.793 | 1.839 | 0.38 | |||||||||
Tumor grade | Well and moderately | 1 | |||||||||||
Poorly | 1.574 | 0.889 | 2.787 | 0.119 | |||||||||
Tumor location | RCC | 1 | |||||||||||
LCC | 0.997 | 0.714 | 1.392 | 0.984 | |||||||||
Tumor stage | II | 1 | 1 | ||||||||||
III | 2.99 | 2.109 | 4.238 | < 0.001 | 2.281 | 1.485 | 3.505 | < 0.001 | |||||
pT stage | T1 + 2 | 1 | < 0.001 | ||||||||||
T2 | 1.912 | 0.999 | 3.662 | 0.05 | |||||||||
T4 | 9.308 | 4.478 | 19.348 | < 0.001 | |||||||||
Number of removed lymph nodes | ≥ 12 | 1 | 1 | ||||||||||
< 12 | 2.166 | 1.421 | 3.301 | < 0.001 | 1.751 | 1.13 | 2.712 | 0.012 | |||||
pN | N0 | 1 | < 0.001 | ||||||||||
N1 | 2.779 | 1.908 | 4.047 | < 0.001 | |||||||||
N2 | 3.56 | 2.237 | 5.664 | < 0.001 | |||||||||
PNI | Negative | 1 | 1 | ||||||||||
Positive | 3.953 | 2.801 | 5.578 | < 0.001 | 2.277 | 1.549 | 3.347 | < 0.001 | |||||
LVI | Negative | 1 | 1 | ||||||||||
Positive | 3.372 | 2.382 | 4.774 | < 0.001 | 1.825 | 1.221 | 2.728 | 0.003 | |||||
Surgical margin | Negative | 1 | |||||||||||
Positive | 3.884 | 1.436 | 10.505 | 0.008 | |||||||||
Adjuvant treatment | No | 1 | 1 | ||||||||||
Yes | 0.591 | 0.346 | 0.954 | 0.041 | 0.514 | 0.323 | 0.82 | 0.005 |
Table 4 Factors affecting overall survival
Univariate analysis | Multivariate analysis | ||||||||||||
HR | 95%CI | P | HR | 95%CI | P | ||||||||
Age (yr) | < 65 | 1 | 1 | ||||||||||
≥ 65 | 4.136 | 2.731 | 6.263 | < 0.001 | 4.049 | 2.578 | 6.358 | < 0.001 | |||||
Gender | Male | 1 | |||||||||||
Female | 0.951 | 0.636 | 1.423 | 0.808 | |||||||||
Family history | No | 1 | |||||||||||
Yes | 0.306 | 0.043 | 2.196 | 0.239 | |||||||||
Smoking status | No | 1 | |||||||||||
Yes | 0.815 | 0.533 | 1.247 | 0.346 | |||||||||
Alcohol using status | No | 1 | |||||||||||
Yes | 0.348 | 0.086 | 1.411 | 0.139 | |||||||||
Mode of surgery | Elective | 1 | |||||||||||
Emergent | 1.342 | 0.812 | 2.219 | 0.252 | |||||||||
DM | No | 1 | |||||||||||
Yes | 1.683 | 0.953 | 2.972 | 0.073 | |||||||||
HT | No | 1 | |||||||||||
Yes | 3.067 | 2.035 | 4.623 | < 0.001 | |||||||||
Histology | Adenocarcinoma | 1 | |||||||||||
Mucinous adenocarcinoma | 1.213 | 0.733 | 2.006 | 0.452 | |||||||||
Tumor grade | Well and moderately | 1 | |||||||||||
Poorly | 1.036 | 0.453 | 2.369 | 0.933 | |||||||||
Tumor location | RCC | 1 | |||||||||||
LCC | 0.807 | 0.539 | 1.208 | 0.297 | |||||||||
Tumor stage | II | 1 | 1 | ||||||||||
III | 2.363 | 1.57 | 3.557 | < 0.001 | 1.723 | 1.037 | 2.863 | 0.036 | |||||
pT stage | T1 + 2 | 1 | < 0.001 | ||||||||||
T2 | 4.836 | 1.526 | 15.326 | 0.007 | |||||||||
T4 | 21.34 | 6.162 | 73.897 | < 0.001 | |||||||||
Number of removed lymph nodes | ≥ 12 | 1 | |||||||||||
< 12 | 1.402 | 0.897 | 2.192 | 0.138 | |||||||||
pN | N0 | 1 | < 0.001 | ||||||||||
N1 | 2.122 | 1.353 | 3.327 | 0.001 | |||||||||
N2 | 3.015 | 1.742 | 5.219 | < 0.001 | |||||||||
PNI | Negative | 1 | 1 | ||||||||||
Positive | 3.653 | 2.4 | 5.562 | < 0.001 | 2.198 | 1.374 | 3.517 | 0.001 | |||||
LVI | Negative | 1 | 1 | ||||||||||
Positive | 3.735 | 2.445 | 5.707 | < 0.001 | 2.523 | 1.543 | 4.127 | < 0.001 | |||||
Surgical margin | Negative | 1 | |||||||||||
Positive | 2.57 | 0.633 | 10.435 | 0.187 | |||||||||
Adjuvant treatment | No | 1 | 1 | ||||||||||
Yes | 0.587 | 0.379 | 0.91 | 0.017 | 0.517 | 0.311 | 0.86 | 0.011 |
- Citation: Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420
- URL: https://www.wjgnet.com/1948-5204/full/v10/i11/410.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.410